ESC Premium Access

Do beta-blockers increase the risk for hospitalizations in heart failure with preserved ejection fraction? a secondary analysis of beta-blocker use in the TOPCAT trial

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Daniel Silverman

Medical University of South Carolina, Charleston (United States of America)
0 follower

8 more presentations in this session

Pharmacological treatment of patients with HFrEF: is it really optimized in case of CRT and/or ICD implantation?

Speaker: Professor D. Logeart (Paris, FR)


Evolution of level of evidence c recommendations in european society of cardiology clinical practice guidelines on heart failure

Speaker: Doctor M. Trindade (Lisbon, PT)


Therapy treatment, adherence and persistence in chronic heart failure patients: a populaion study, from 2005 to TO 2012 in Lombardy

Speaker: Doctor S. Scalvini (Lumezzane, IT)


The myocardial tissue Renin-Angiotensin-System (RAS) of the failing heart

Speaker: Doctor N. Pavo (Vienna, AT)


All cause mortality outcomes of various types of stem cell therapies in patients with dilated cardiomyopathy: an updated meta analysis and systematic review

Speaker: Doctor Y. Illahi (Multan, PK)


Access the full session

Poster Session 2 - Treatment of heart failure

Speakers: Doctor D. Silverman, Professor D. Logeart, Doctor M. Trindade, Doctor S. Scalvini, Doctor N. Pavo...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk